Adma Biologics (ADMA) Consolidated Net Income (2011 - 2026)
Adma Biologics (ADMA) posted Consolidated Net Income of $49.88 million for Q3 2026, up 36.9% from $36.43 million a year earlier and up 31.9% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Consolidated Net Income (2011 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Consolidated Net Income at Adma Biologics was $182.41 million, down 12.9% year-over-year; for FY2025, it came in at $146.93 million, down 25.7% from FY2024.
- In prior years, Adma Biologics' Consolidated Net Income was $197.67 million in FY2024, -$28.24 million in FY2023, -$65.9 million in FY2022 and -$71.4 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly Consolidated Net Income since Q4 2024.
- On a year-over-year basis, Consolidated Net Income has increased in each of the last three quarters, with growth averaging 17.0% over the last seven quarters.
- According to Business Quant data, Consolidated Net Income for the three prior quarters was $37.82 million (Q2 2026), $45.33 million (Q1 2026) and $49.38 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 49.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 49.88 Mn |
| Jun 30, 2026 | 37.82 Mn |
| Mar 31, 2026 | 45.33 Mn |
| Dec 31, 2025 | 49.38 Mn |
| Sep 30, 2025 | 36.43 Mn |
| Jun 30, 2025 | 34.22 Mn |
| Mar 31, 2025 | 26.90 Mn |
| Dec 31, 2024 | 111.90 Mn |
| Sep 30, 2024 | 35.91 Mn |
| Jun 30, 2024 | 32.06 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | -17.65 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | -6.37 Mn |
| Mar 31, 2023 | -6.79 Mn |
| Dec 31, 2022 | -11.79 Mn |
| Sep 30, 2022 | -14.89 Mn |
| Jun 30, 2022 | -13.75 Mn |
| Mar 31, 2022 | -18.17 Mn |
| Dec 31, 2021 | -16.50 Mn |
API Access
Adma Biologics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();